AZ sues McKesson over inflated drug prices
The state of Arizona has filed a lawsuit against McKesson Corp., alleging the nation's largest drug wholesaler has artificially inflated the prices of more than 400 brand-name prescription drugs. Among the drugs that are alleged to have been marked-up inappropriately are: Allegra, Azmacort, Celebrex, Coumadin, Flonase, Lipitor, Neurontin, Nexium, Prevacid and Valium. The complaint was filed in Maricopa County Superior Court, alleging that the scheme began in 2000 to mark up the average wholesale price of many prescription drugs, costing consumers millions of dollars, according to Arizona Attorney General Tom Horne. The San Francisco company controls about one-third of the national wholesale drug distribution market, Horne said.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- PCI: Concerns Mount About Appropriateness
- MA an Insurance Proving Ground for Providers
- Transforming Cancer Care
- Targeting Self-Insured Populations